Cargando…
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
The clinical effectiveness of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear. METHODS. We linked 4 national registries to retrospectively identify laboratory-confirmed SARS-CoV-2 infection...
Autores principales: | Callaghan, Chris J., Mumford, Lisa, Curtis, Rebecca M. K., Williams, Sarah V., Whitaker, Heather, Andrews, Nick, Lopez Bernal, Jamie, Ushiro-Lumb, Ines, Pettigrew, Gavin J., Thorburn, Douglas, Forsythe, John L. R., Ravanan, Rommel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862680/ https://www.ncbi.nlm.nih.gov/pubmed/34982758 http://dx.doi.org/10.1097/TP.0000000000004059 |
Ejemplares similares
-
Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea
Publicado: (2021) -
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
por: Whitaker, Heather J., et al.
Publicado: (2022) -
Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
por: Phumisantiphong, Uraporn, et al.
Publicado: (2023) -
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
por: Eyre, David W., et al.
Publicado: (2021)